Previous 10 | Next 10 |
ANAHEIM, CA, March 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company) , a developer and provider of advanced solutions in the treatment of substance abuse disorders, today announced that the Company’s subsidiary, BioCorRx Pharmaceutica...
ANAHEIM, CA, March 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTC: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of substance abuse disorders, today announced that it has promoted Dr. Balbir S. Brar to Senior VP ...
ANAHEIM, CA, March 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (“Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, announced today that the Company has been invited to present at the 31st A...
ANAHEIM, CA, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (“Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, announced today that it has engaged IRISYS, LLC, a contract pharmaceutical ...
ANAHEIM, CA, Feb. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioCorRx Inc. (OTCQB: BICX) (“Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, announced today the addition of two new independent directors, Louis Lu...
NEW YORK , Feb. 25, 2019 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, announced that the presentations from the February 20 th , 2019 conference are now available for on-demand viewing at VirtualInvestorConferences.com. LINK: ...
ANAHEIM, CA, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, announced today the formation of its Scientific Advisory Board (SAB) wi...
NEW YORK , Feb. 15, 2019 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series. Individual investors, institutional investors, advisors and analysts are invited to...
ANAHEIM, Calif. , Feb. 15, 2019 /PRNewswire/ -- BioCorRx Inc. (BICX), based in Anaheim, CA , Leader in addiction treatment solutions and drug development implementation, today announced that Brady Granier , CEO/President and Lourdes Felix , CFO/COO, will present live at ...
PHOENIX, Jan. 28, 2019 (GLOBE NEWSWIRE) -- The Uptick Newswire Stock Day Podcast welcomed BioCorRx Inc. (OTCQB: BICX ) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions. President, CEO, and Director of BioCorRx Inc Brady Gra...
News, Short Squeeze, Breakout and More Instantly...
ANAHEIM, CA - ( NewMediaWire ) - May 16, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the three months ended March 31, 2024, and...
ANAHEIM, CA - ( NewMediaWire ) - April 03, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer of innovative treatment programs for substance use and related disorders, today announced that its subsidiary BioCorRx Pharmaceuticals Inc., a clinical-stage biopharmace...
ANAHEIM, CA - ( NewMediaWire ) - April 02, 2024 - BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the year ended December 31, 2023, and reported on...